ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures. It develops NervAlign Nerve Cuff, a protective wrap used to protect repaired injured nerves; NervAlign Nerve Graft, a size-based range of off-the-shelf nerve grafts for the repair of damaged nerves; and NervAlign bionic nerve to produce a replacement nerve that contains shaped ionic polymers, which would enable the stimulation of the distal end of a nerve injury. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
Metrics to compare | RNV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNVPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.2x | −4.8x | −0.5x | |
PEG Ratio | - | −0.14 | 0.00 | |
Price/Book | 2.0x | 3.5x | 2.6x | |
Price / LTM Sales | 59.1x | 3.7x | 3.3x | |
Upside (Analyst Target) | - | 68.2% | 43.5% | |
Fair Value Upside | Unlock | 2.4% | 6.9% | Unlock |